U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022290

ADREVIEW (IOBENGUANE SULFATE I-123)
10mCi/5ML (2mCi/ML)
Marketing Status: Prescription
Active Ingredient: IOBENGUANE SULFATE I-123
Proprietary Name: ADREVIEW
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 10mCi/5ML (2mCi/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N022290
Product Number: 001
Approval Date: Sep 19, 2008
Applicant Holder Full Name: GE HEALTHCARE
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top